EP Patent

EP2213304A1 — Granule, tablet, and their production methods

Assigned to Tomita Pharmaceutical Co Ltd · Expires 2010-08-04 · 16y expired

What this patent protects

A granule comprising a carrier composed of porous calcium silicate; a functional substance which is an oily liquid or a low-melting solid and a water-soluble antioxidizing agent, which are adsorbed on the carrier; and a granulating component. The problem to be solved is to improv…

USPTO Abstract

A granule comprising a carrier composed of porous calcium silicate; a functional substance which is an oily liquid or a low-melting solid and a water-soluble antioxidizing agent, which are adsorbed on the carrier; and a granulating component. The problem to be solved is to improve storage stability of a powdered or tableted functional substance, for example, vitamin A to the level causing no problem in practical use.

Drugs covered by this patent

Patent Metadata

Patent number
EP2213304A1
Jurisdiction
EP
Classification
—
Expires
2010-08-04
Drug substance claim
No
Drug product claim
No
Assignee
Tomita Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.